Ellen Weber

497 total citations
27 papers, 370 citations indexed

About

Ellen Weber is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pharmacology. According to data from OpenAlex, Ellen Weber has authored 27 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Ellen Weber's work include Opioid Use Disorder Treatment (6 papers), Substance Abuse Treatment and Outcomes (4 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). Ellen Weber is often cited by papers focused on Opioid Use Disorder Treatment (6 papers), Substance Abuse Treatment and Outcomes (4 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). Ellen Weber collaborates with scholars based in United States and Germany. Ellen Weber's co-authors include Diane E. Hoffmann, E. Gerlach, G. Schlierf, William J. Parish, P. Oster, Tami L. Mark, Wolfgang Kruse, Thorsten Nikolaus, Marley W. Watkins and Eberhard Morgenstern and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Geriatrics Society and American Journal of Preventive Medicine.

In The Last Decade

Ellen Weber

24 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Weber United States 10 96 68 56 53 46 27 370
D K Luscombe United Kingdom 12 77 0.8× 59 0.9× 66 1.2× 50 0.9× 72 1.6× 43 931
Wayne D. Mitchell United States 11 37 0.4× 38 0.6× 51 0.9× 63 1.2× 46 1.0× 18 428
J S Kelloway United States 10 109 1.1× 48 0.7× 25 0.4× 22 0.4× 114 2.5× 16 581
Varsha Patel India 11 35 0.4× 49 0.7× 46 0.8× 31 0.6× 47 1.0× 37 335
Suzanne Novak United States 11 49 0.5× 57 0.8× 37 0.7× 163 3.1× 35 0.8× 17 415
Sophia M. Schild United States 6 32 0.3× 36 0.5× 59 1.1× 47 0.9× 38 0.8× 10 391
Cinzia Pezzolesi United Kingdom 7 67 0.7× 65 1.0× 40 0.7× 37 0.7× 27 0.6× 8 486
Michael J. Reichgott United States 13 24 0.3× 33 0.5× 120 2.1× 141 2.7× 21 0.5× 27 575
Frasia Oosthuizen South Africa 14 23 0.2× 63 0.9× 56 1.0× 36 0.7× 52 1.1× 63 577
Bradley R. Williams United States 14 101 1.1× 25 0.4× 96 1.7× 62 1.2× 98 2.1× 34 722

Countries citing papers authored by Ellen Weber

Since Specialization
Citations

This map shows the geographic impact of Ellen Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Weber more than expected).

Fields of papers citing papers by Ellen Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Weber. The network helps show where Ellen Weber may publish in the future.

Co-authorship network of co-authors of Ellen Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Weber. A scholar is included among the top collaborators of Ellen Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Weber. Ellen Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mark, Tami L., et al.. (2023). The cost of opioid use disorder-related conditions in Medicare. Drug and Alcohol Dependence. 244. 109778–109778. 5 indexed citations
2.
Parish, William J., et al.. (2022). Substance Use Disorders Among Medicare Beneficiaries: Prevalence, Mental and Physical Comorbidities, and Treatment Barriers. American Journal of Preventive Medicine. 63(2). 225–232. 22 indexed citations
3.
Parish, William J., Tami L. Mark, Gary A. Zarkin, & Ellen Weber. (2021). The association of Medicare Part D prior authorization for buprenorphine–naloxone with adherence to opioid use disorder treatment guidelines in the United States. Addiction. 117(1). 141–150. 5 indexed citations
4.
Mark, Tami L., William J. Parish, Ellen Weber, & Gary A. Zarkin. (2021). Prior Authorization for Opioid Use Disorder Versus Pain Medications: Lessons Learned for Parity Enforcement. Journal of Studies on Alcohol and Drugs. 82(2). 214–218. 5 indexed citations
5.
Weber, Ellen. (2010). Failure of Physicians to Prescribe Pharmacotherapies for Addiction: Regulatory Restrictions and Physician Resistance. 13(1). 49. 12 indexed citations
6.
Hoffmann, Diane E. & Ellen Weber. (2010). Medical Marijuana and the Law. New England Journal of Medicine. 362(16). 1453–1457. 88 indexed citations
7.
Weber, Ellen. (2007). Child Welfare Interventions for Drug-Dependent Pregnant Women: Limitations of a Non-Public Health Response. SSRN Electronic Journal. 6 indexed citations
8.
Weber, Ellen, et al.. (2005). Civil legal needs of individuals in drug treatment. Journal of Substance Abuse Treatment. 28(2). 205–211.
9.
Weber, Ellen. (2004). Bridging the Barriers: Public Health Strategies for Expanding Drug Treatment in Communities. SSRN Electronic Journal. 2 indexed citations
10.
Stevenson, Howard C., et al.. (1995). HIV prevention beliefs among urban African-American youth. Journal of Adolescent Health. 16(4). 316–323. 20 indexed citations
11.
Vries, J. X. de, et al.. (1993). Comparative Plasma Disposition and Anticoagulant Activities of Racemic Phenprocoumon and Its Metabolites in Rats. Pathophysiology of Haemostasis and Thrombosis. 23(1). 13–18. 6 indexed citations
12.
Kruse, Wolfgang, et al.. (1992). Measurement of Drug Compliance by Continuous Electronic Monitoring: A Pilot Study in Elderly Patients Discharged From Hospital. Journal of the American Geriatrics Society. 40(11). 1151–1155. 54 indexed citations
13.
Kolbe, Karin, et al.. (1989). Pharmacokinetics of nicotinic acid – salicylic acid interaction. Clinical Pharmacology & Therapeutics. 46(6). 642–647. 24 indexed citations
14.
Gundert‐Remy, Ursula, et al.. (1984). The influence of dimetindene maleate (Fenistil®) on the pharmacokinetic profile of betamethasone. Biopharmaceutics & Drug Disposition. 5(3). 291–295. 1 indexed citations
15.
Gundert‐Remy, Ursula, et al.. (1983). Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Clinical Pharmacology & Therapeutics. 33(5). 656–662. 8 indexed citations
16.
Weber, Ellen, et al.. (1963). Über beziehungen zwischen glykogengehalt und retraktionsverögen von blutplättchen. Biochemical Pharmacology. 12(2). 145–156. 4 indexed citations
17.
Weber, Ellen. (1960). Die Beeinflussung der säurelöslichen Phosphor-Verbindungen in Rattenerythrocyten durch intraperitoneale Verabreichung von Adenosin, AMP, ATP und Guanosin. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 321(Jahresband). 10–28.
18.
Gerlach, E., et al.. (1955). Einige neue L�sungsmittel f�r die Papierchromatographie von Phosphors�ure-Estern. Naunyn-Schmiedeberg s Archives of Pharmacology. 226(1). 28 indexed citations
19.
Gerlach, E. & Ellen Weber. (1955). Papierchromatographische Trennungsmethode f�r die s�urel�slichen Phosphorverbindungen aus Nierengewebe. Naunyn-Schmiedeberg s Archives of Pharmacology. 224(5-6). 18 indexed citations
20.
Weber, Ellen. (1954). Mass und Zahl im Kunstwerk.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D K Luscombe Breakdown of academic impact, for papers by Wayne D. Mitchell Breakdown of academic impact, for papers by J S Kelloway Breakdown of academic impact, for papers by Varsha Patel Breakdown of academic impact, for papers by Suzanne Novak Breakdown of academic impact, for papers by Sophia M. Schild Breakdown of academic impact, for papers by Cinzia Pezzolesi Breakdown of academic impact, for papers by Michael J. Reichgott Breakdown of academic impact, for papers by Frasia Oosthuizen Breakdown of academic impact, for papers by Bradley R. Williams
Rankless by CCL
2026